Back to top

New Sports Medicine Gears from 3M's ACE

Read MoreHide Full Article

3M Company’s (MMM - Free Report) ACE Brand recently introduced an innovative line of sports medicine gears, christened ACE Brand Sports Medicine Products. These products have ACE Brand’s trusted technology and will protect athletes from injuries.

The new product line is well suited for sports like baseball, basketball, football, golf, hockey, soccer, tennis and volleyball. The wide spectrum of sports accessories include new custom dial ankle brace, elbow strap and knee strap, along with additional braces as well as elastic bandages, protective gear, tapes/underwraps and hot/cold therapy.

ACE Brand has partnered with leading youth sports organization Little League Baseball and Softball for this launch. The partnership gives additional brand recognition and further improves visibility among athletes. With its expansion into the new sporting goods category, 3M aims to extend its commitment to provide athletes with efficient protection gears.

3M remains focused on inventing new products and maintaining its competitive advantage worldwide. The rise in demand for such innovative 3M products and services is likely to augment the company’s revenues in the long run

3M and its subsidiaries operate as a diversified technology company with manufacturing operations spread across 70 countries. It has more than 35 business units organized into five business segments: Industrial, Safety and Graphics, Electronics and Energy, Health Care, and Consumer

3M currently has a Zacks Rank #4 (Sell). Other stocks that look promising and are worth a look now are Hutchison Whampoa Ltd ,  having  a Zacks Rank #1 (Strong Buy), Federal Signal Corp. (FSS - Free Report) and ITT Corporation  ((ITT - Free Report) ), both having a Zacks Rank #2 (Buy).


In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

3M Company (MMM) - free report >>

ITT Inc. (ITT) - free report >>

Federal Signal Corporation (FSS) - free report >>

More from Zacks Analyst Blog

You May Like